United States · Series E startup
Funding summaryUpdated 26 Oct 2026
$222Mraised across 2 rounds since 2025, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $97M sold, first sale Apr 2025
From Thyme Care's own website: 3 founders, 14 on the team.
AdvisersBrenton FargnoliElizabeth CanisEthan Basch
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Thyme Care's investors include Andreessen Horowitz, Bessemer Venture Partners, Foresite Capital, Frist Cressey Ventures and Morgan Health, and 8 more on record. Morgan Health led its latest round.
Thyme Care has raised $222M across 2 rounds since 2025.
Thyme Care's most recent round was a Series E of $125M in Sept 2026, led by Morgan Health.
Its most recent round, $125M in Sept 2026, is also its largest on record.
Thyme Care's first round on record, in Sept 2025, was backed by Andreessen Horowitz, Bessemer Venture Partners and Foresite Capital and 1 others.
Thyme Care's latest named round is a Series E, in Sept 2026.
Thyme Care is based in the United States.
Morgan Health led the Series E in 2026.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
